Literature DB >> 9918602

Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: an in vivo electrochemical study.

M A Hebert1, G A Gerhardt.   

Abstract

Age-related changes in the capacity, rate, and modulation of dopamine (DA) uptake within the striatum and the nucleus accumbens core of Fischer 344 rats were investigated using in vivo electrochemical recordings coupled with local drug application techniques. Equimolar amounts of DA were pressure ejected into the striatum and the nucleus accumbens of 6-, 12-, 18-, and 24-month old rats. The DA ejections produced larger DA signal amplitudes in the older rats, suggesting age-related differences in the capacity to clear extracellular DA. Within the striatum, the capacity and rate of DA uptake were reduced by 50% in the aged groups (18 and 24 months) compared with the younger rats (6 and 12 months). In the nucleus accumbens, significant reductions in DA uptake capacity and rate were observed in the 24-month group. In both brain regions and in all age groups studied, the rate of DA uptake was found to be concentration-dependent until a maximal rate was reached. The maximum rate of DA transport was significantly reduced in both the striatum and the nucleus accumbens of aged rats (18 and 24 months versus 6 and 12 months). The ability of nomifensine, an inhibitor of the DA transporter, to modulate DA signal amplitudes in the striatum and the nucleus accumbens was also decreased with age (24 months versus 6 months). Taken together, these findings demonstrate substantial age-related deficits in DA uptake processes within the striatum and the nucleus accumbens, consistent with the hypothesis that DA uptake may be slowed in aged animals to compensate for reductions in DA release.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918602

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Differential effects of amphetamine isomers on dopamine release in the rat striatum and nucleus accumbens core.

Authors:  Paul E A Glaser; Theresa C Thomas; B Matthew Joyce; F Xavier Castellanos; Greg A Gerhardt
Journal:  Psychopharmacology (Berl)       Date:  2004-09-30       Impact factor: 4.530

2.  Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF.

Authors:  Ofelia M Littrell; Ann-Charlotte Granholm; Greg A Gerhardt; Heather A Boger
Journal:  Pharmacol Biochem Behav       Date:  2013-01-02       Impact factor: 3.533

3.  Gene transfer provides a practical means for safe, long-term, targeted delivery of biologically active neurotrophic factor proteins for neurodegenerative diseases.

Authors:  Christopher D Herzog; Kathie M Bishop; Lamar Brown; Alistair Wilson; Jeffrey H Kordower; Raymond T Bartus
Journal:  Drug Deliv Transl Res       Date:  2011-10       Impact factor: 4.617

4.  Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.

Authors:  Sucharita S Somkuwar; Kathleen M Kantak; Linda P Dwoskin
Journal:  J Neurosci Methods       Date:  2015-02-11       Impact factor: 2.390

5.  Young and middle-aged rats exhibit isometric forelimb force control deficits in a model of early-stage Parkinson's disease.

Authors:  Crystal S Bethel-Brown; Jill K Morris; John A Stanford
Journal:  Behav Brain Res       Date:  2011-07-08       Impact factor: 3.332

6.  Differential effects of amphetamine and GBR-12909 on orolingual motor function in young vs aged F344/BN rats.

Authors:  Susan Smittkamp; Heather Spalding; Hongyu Zhang; John A Stanford
Journal:  Psychopharmacology (Berl)       Date:  2014-06-13       Impact factor: 4.530

7.  Adderall produces increased striatal dopamine release and a prolonged time course compared to amphetamine isomers.

Authors:  B Matthew Joyce; Paul E A Glaser; Greg A Gerhardt
Journal:  Psychopharmacology (Berl)       Date:  2006-10-10       Impact factor: 4.530

8.  Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease.

Authors:  Lifen Zhang; Weidong Le; Wenjie Xie; John A Dani
Journal:  Neurobiol Aging       Date:  2011-04-30       Impact factor: 4.673

9.  Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice.

Authors:  Ofelia M Littrell; Francois Pomerleau; Peter Huettl; Stewart Surgener; Jacqueline F McGinty; Lawrence D Middaugh; Ann-Charlotte Granholm; Greg A Gerhardt; Heather A Boger
Journal:  Neurobiol Aging       Date:  2010-12-08       Impact factor: 4.673

10.  Decreased dopamine D4 receptor expression increases extracellular glutamate and alters its regulation in mouse striatum.

Authors:  Theresa Currier Thomas; David K Grandy; Greg A Gerhardt; Paul E A Glaser
Journal:  Neuropsychopharmacology       Date:  2008-06-04       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.